These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8744821)

  • 1. Dynamic gadolinium-DOTA-enhanced MR imaging at 1.0 T. Value in the differentiation of hepatic tumors.
    Soyer P; Laissy JP; Sibert A; Menu Y
    Clin Imaging; 1996; 20(2):118-25. PubMed ID: 8744821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
    Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
    AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumors.
    Van Beers B; Demeure R; Pringot J; Defalque D; Geubel A; Gigot JF; Jamart J
    AJR Am J Roentgenol; 1990 Mar; 154(3):515-9. PubMed ID: 2154913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of hepatic neoplasms: spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging.
    Abbas YA; Kressel HY; Wehrli FW; Gefter WB; Dinsmore BJ; Chan TW; Oleaga L; Milestone BN; Outwater EK
    Magn Reson Q; 1991 Oct; 7(4):275-92. PubMed ID: 1790113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
    Quillin SP; Atilla S; Brown JJ; Borrello JA; Yu CY; Pilgram TK
    Magn Reson Imaging; 1997; 15(3):275-85. PubMed ID: 9201674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Gd-DOTA-enhanced MR imaging of hepatic metastases from pancreatic neuroendocrine tumors.
    Soyer P; Tidjani K; Laissy JP; Sibert A; Menu Y
    Eur J Radiol; 1994 Aug; 18(3):180-4. PubMed ID: 7957287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
    Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
    Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
    Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
    Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.
    Yoshida H; Itai Y; Ohtomo K; Kokubo T; Minami M; Yashiro N
    Radiology; 1989 May; 171(2):339-42. PubMed ID: 2539606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T.
    Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B
    J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic tumors: magnetization transfer MR imaging with gadolinium enhancement.
    Onaya H; Yoshioka H; Itai Y; Niitsu M; Anno I; Okumura T
    J Magn Reson Imaging; 1995; 5(3):273-9. PubMed ID: 7633103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.
    Hamm B; Fischer E; Taupitz M
    J Comput Assist Tomogr; 1990; 14(2):205-16. PubMed ID: 2312848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.
    Cheng WZ; Zeng MS; Yan FH; Rao SX; Shen JZ; Chen CZ; Zhang SJ; Shi WB
    World J Gastroenterol; 2007 Sep; 13(36):4891-6. PubMed ID: 17828821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.
    Mitchell DG; Saini S; Weinreb J; De Lange EE; Runge VM; Kuhlman JE; Parisky Y; Johnson CD; Brown JJ; Schnall M
    Radiology; 1994 Oct; 193(1):49-57. PubMed ID: 8090921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.